glp 1 news As GLP-1 Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale Beyond Weight Loss: How GLP-1
Description
Four additional states have coverage in place but only for older drugs that are not GLP-1s
Baseline characteristic and outcomes of CVOTs are listed in Table 2
Share When people begin GLP-1 therapy for weight loss or metabolic support, the number one question I hear is: How long will it take before I feel a difference
Care that starts online and continues with you Meet with a licensed provider by video
Its a direct investment in a healthier, more vibrant, and potentially less expensive future
Full data is expected in mid-2026: which would put an FDA decision on the drug into late 2027 or 2028
